At a glance
ClinicalIndex Comparison RecordPhase 2Completed
Drug / intervention
calcium +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Oral Calcium in Pregnant Women With Hypertension
National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated May 13, 2016
In Brief
A Phase 2 clinical trial evaluating dietary supplements and calcium for Cardiovascular Diseases and 5 related conditions. Completed.
Detailed Summary
To determine of providing calcium supplementation to women with pre-existing hypertension reduces the level of blood pressure, requirement for antihypertensive drugs, and incidence of pre-eclampsia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Hypertension, Pre-Eclampsia, Pregnancy Toxemias, Vascular Diseases
Countries--
Collaborators--
Timeline
Phase 2CompletedFinished
19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 1993
Study CompletionJul 1999
First PostedOct 1999
TodayJul 2026
First PostedOct 28, 1999
Enrollment StartAug 1, 1993
Study CompletionJul 1, 1999
TodayJul 2, 2026
Posted 26.7 years ago
Interventions
dietary supplementsbehavioral
calciumdrug